ClinicalTrials.gg
Not yet recruitingNCT04146714YP-HEALTHUpdated May 22, 2024

Substance Use Screening to Encourage Behavior Change Among Young People in Primary Care

An interventional study of Substance use questionnaire and Physical activity questionnaire in Substance Use, Binge Drinking and Cannabis Use, sponsored by Prof. Dagmar M. Haller. Not yet recruiting at 1 site in Switzerland. Open to participants aged 14 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-22.

Primary conditionBinge DrinkingRegistry: Substance-Related DisordersReclassifiedWhy we changed it
Registry
Substance-Related Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Binge Drinking
Why
  1. The study's listed conditions name Binge Drinking, a narrower term within Substance-Related Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Prof. Dagmar M. Haller · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
840
Allocation
Randomized
Ages
14 Years to 24 Years
Sex
All
01

Study summary

This study evaluates whether completing a short screening questionnaire about health behaviours in the waiting room before a primary care consultation decreases excessive substance use in young people aged 14 to 24 years. Young people consulting a primary care physician will randomly receive either a questionnaire about substance use or a questionnaire about physical activity. They will be contacted again 3, 6 and 12 months later and asked to complete a questionnaire about substance use. The proportion of young people with excessive substance use in each group will be compared. The researchers hypothesise that at three months this proportion will be lower in the group of young people having completed the initial questionnaire about substance use when compared to the group having completed the questionnaire about physical activity.

Read the detailed description

Background: Excessive alcohol and other substance use often begin in adolescence and contribute extensively to the development of non-communicable diseases and lifelong morbidity/mortality. In Switzerland, the prevalence of binge drinking (the most common mode of alcohol excess in adolescence) and other excessive substance use in young people is high, both in the general and in the primary care population. Since most young people visit a primary care physician at least once in any year, primary care offers an ideal context to individualize the preventive messages delivered in the community to favor behavior change.

Primary care physicians are encouraged to screen and provide brief interventions addressing excessive alcohol and other substance use in young people, but a range of barriers such as time constraints and insufficient training limit the implementation of these recommendations. Finding new ways of building on the potential of primary care whilst addressing these barriers is essential.

Several recent trials of brief primary care interventions showed substantial reductions (20% to 30%) in the proportion of participants who were excessive substance users at follow-up but no statistically significant differences between the intervention and control groups. Key authors have hypothesized that this could be due to assessment reactivity, i.e. when pre-intervention assessment itself encourages behavior change and thus serves as an intervention. Indeed, screening in the clinical context could act as an intervention and be as effective as a brief intervention within the consultation. To date this hypothesis has not been explored for young people attending primary care.

Methods: One of our previous trials (PRISM-Ado), and a pilot trial published in 2019, inform the methods of this parallel-group randomized controlled trial in primary care. Advisory panels of primary care physicians and young people contributed to the development of this protocol. Recruitment will take place in primary care practices in the French-speaking part of Switzerland. Young people between the ages of 14 and 24 years consulting for any health problem will be eligible. Up to 840 young people (approx 20 per practice) will be included and randomized to complete two different types of confidential pre-consultation screening surveys: one focusing on the assessment of binge drinking and other substance use (intervention group) and the other on physical activity (control group). Both surveys will include identical additional socio-demographic and health-related questions. The primary care physicians will not automatically have access to the answers provided in the surveys and participants will be free to decide if they wish to disclose them to their physician during the consultation. Follow-up phone interviews will take place at 3, 6 and 12 months. They will be identical for all participants and include all questions from the intervention and control questionnaires. The main outcome at 3 months follow-up will be the proportion of patients reporting binge drinking (≥1 episode) in the past 30 days. Secondary outcomes will include the proportion of young people reporting smoking (≥ 1 cigarette a day), electronic cigarette use (≥ once a day) and/or excessive cannabis use (≥1 joint/week) in the past 30 days. Analysis will be by intention to treat and will take into account clustering of participants within practices.

Expected value of the proposed trial: If our intervention proves effective, it will offer a simple, widely expandable method to encourage behavior change in young people consulting in primary care, thus contributing to a much-needed reduction in the burden of non-communicable diseases in the future. In addition, by providing a quantification of the effect of assessment reactivity per se, our study will provide key information for the design of future trials of interventions addressing substance use in young people attending primary care.

02

Conditions studied

  • Substance Use
  • Binge Drinking
  • Cannabis Use
  • Adolescent Behavior

Browse trials for

03

In context

Binge Drinking Reclassified

71 studies on the registry are indexed under Binge Drinking; 20 are open to participants now.

This study's planned enrollment of 840 is above the median of 120 across 64 interventional studies indexed under Binge Drinking.

Browse Binge Drinking studies →

Lead sponsor

This is the only study on the registry with Prof. Dagmar M. Haller as lead sponsor.

Compared within Binge Drinking, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Substance-Related Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
14 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 14 to 24 years consulting at the participating primary care practice for any motive.

Exclusion criteria

Exclusion Criteria:

  • Acute illness requiring immediate attention of the physician
  • Severe mental health conditions requiring treatment in a specialized setting
  • Young person not consulting as a patient at the practice (e.g. accompanying friend or partner)
  • Inability to read the trial information in French or to provide independent consent.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
840 participants (estimated)

Study arms

  • Experimental
    Substance use screening

    Participants complete a substance use questionnaire (=intervention).

    Other: Substance use questionnaire

  • Active comparator
    Physical activity screening

    Participants complete a physical activity questionnaire (=control).

    Other: Physical activity questionnaire

Interventions

  • OtherSubstance use questionnaire

    Screening questionnaire about substance use based on the Detection of Alcohol and Drug Problems in Adolescents (DEP-ADO) survey.

  • OtherPhysical activity questionnaire

    Screening questionnaire about physical activity, based on the short version of the International Physical Activity Questionnaire (IPAQ).

06

What researchers measure

Primary outcomes

  1. Proportion of patients reporting one or more episodes of binge drinking in the past 30 days.

    Patient self-report on follow-up telephone questionnaire. Binge drinking is defined as the consumption of five or more standard drinks in one occasion.

    Time frame: 3 months

Secondary outcomes

  1. Proportion of patients reporting smoking one or more cannabis joints per week in the last 30 days.

    Patient self-report on follow-up telephone questionnaire.

    Time frame: 3 months

  2. Proportion of patients reporting smoking one or more cannabis joints per week in the last 30 days.

    Patient self-report on follow-up telephone questionnaire.

    Time frame: 6 months

  3. Proportion of patients reporting smoking one or more cannabis joints per week in the last 30 days.

    Patient self-report on follow-up telephone questionnaire.

    Time frame: 12 months

  4. Proportion of patients reporting smoking at least one cigarette per day in the last 30 days.

    Patient self-report on follow-up telephone questionnaire.

    Time frame: 3 months

  5. Proportion of patients reporting smoking at least one cigarette per day in the last 30 days.

    Patient self-report on follow-up telephone questionnaire.

    Time frame: 6 months

  6. Proportion of patients reporting smoking at least one cigarette per day in the last 30 days.

    Patient self-report on follow-up telephone questionnaire.

    Time frame: 12 months

  7. Proportion of patients reporting electronic cigarette use at least once per day in the last 30 days.

    Patient self-report on follow-up telephone questionnaire.

    Time frame: 3 months

  8. Proportion of patients reporting electronic cigarette use at least once per day in the last 30 days.

    Patient self-report on follow-up telephone questionnaire.

    Time frame: 6 months

  9. Proportion of patients reporting electronic cigarette use at least once per day in the last 30 days.

    Patient self-report on follow-up telephone questionnaire.

    Time frame: 12 months

  10. Proportion of patients reporting one or more episodes of binge drinking in the past 30 days.

    Patient self-report on follow-up telephone questionnaire. Binge drinking is defined as the consumption of five or more standard drinks in one occasion.

    Time frame: 6 months

  11. Proportion of patients reporting one or more episodes of binge drinking in the past 30 days.

    Patient self-report on follow-up telephone questionnaire. Binge drinking is defined as the consumption of five or more standard drinks in one occasion.

    Time frame: 12 months

07

Study locations

1 site
  • University Institute for Primary Care, Faculty of Medicine, University of Geneva
    Geneva, Switzerland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04146714
Lead sponsor
Prof. Dagmar M. Haller
Responsible party
Prof. Dagmar M. Haller (Professor, University of Geneva, Switzerland) — Sponsor-investigator
First posted
Oct 31, 2019
Start date
Jan 2025 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
May 22, 2024

Study contacts

Dagmar M Haller, MD, PhD
Contact
dagmar.haller-hester@unige.ch
+41 22 379 50 61
Eva Pfarrwaller, MD
Contact
eva.pfarrwaller@unige.ch
+41 22 379 43 90
Dagmar M Haller, MD,PhD
principal investigator · Faculty of Medicine, University of Geneva

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion